
Asracef-S 375mg Injection
Marketer
Asrawell Lifecare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Asracef-S 375mg Injection
Asracef-S 375mg Injection, a dual-action medication, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection progression. Administration must be overseen by a medical professional; strict adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require urgent medical care. Prior to use, inform your physician of all current medications and pre-existing health conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't impair driving ability, avoid operating vehicles if experiencing somnolence or dizziness. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order tests to monitor the medication's impact.
Primary Ingredients of Asracef-S 375mg Injection
No text provided to rephrase.
Uses of Asracef-S 375mg Injection
Infections caused by bacteria
Major Benefits of Asracef-S 375mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Asracef-S 375mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Asracef-S 375mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Asracef-S 375mg Injection works:
Asracef-S 375mg Injection unites Ceftriaxone, a crucial antibiotic, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam complements this by countering bacterial resistance mechanisms, thereby bolstering Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no reported adverse reactions from concomitant use of Asracef-S 375mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Asracef-S, 375mg, is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingCAUTION
The administration of Asracef-S 375mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Asracef-S 375mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Asracef-S 375mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Asracef-S 375mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Altering the Asracef-S 375mg Injection dosage is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Asracef-S 375mg Injection :
Omit a dose of Asracef-S 375mg Injection? Seek medical advice immediately.
Facts to Know About Asracef-S 375mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Drugs combating infection |
